News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Savient Pharmaceuticals, Inc. (SVNT) Announces Exploration Of Strategic Alternatives For Rosemont Pharmaceuticals Ltd. (BTGC) Subsidiary Including Potential Spin Out Or Sale Of Business



2/17/2006 11:57:43 AM

Savient Pharmaceuticals (NASDAQ: SVNT) today announced that its Board of Directors has engaged Citigroup Corporate and Investment Banking to explore strategic alternatives for its wholly-owned subsidiary, Rosemont Pharmaceuticals, including the potential spin out or sale of the business. Rosemont is a leading developer, manufacturer and marketer of high quality oral liquid medicines in the United Kingdom.

Read at BioSpace.com
Read at AP


comments powered by Disqus
BioSpace.com
AP
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES